Erratum: 3, 30-diindolylmethane exhibits antileukemic activity in vitro and in vivo through a Akt-dependent process (PLoS ONE (2020)7:2(e31783)dOI: 10.1371/journal.pone.0031783);3, 3′-Diindolylmethane exhibits antileukemic activity in vitro and in vivo through a Akt-dependent process

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Gao, Ning ^a,b   Cheng, Senping ^b   Budhraja, Amit ^b   Liu, E Hu ^a   Chen, Jieping ^a   Chen, Deying ^a   Yang, Zailin ^a   Luo, Jia ^b   Shi, Xianglin ^b   Zhang, Zhuo ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3,3' DIINDOLYLMETHANE; CASPASE; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN MCL 1; PROTEIN P21; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 3,3'-DIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; CHROMONE DERIVATIVE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; INDOLE DERIVATIVE; MORPHOLINE DERIVATIVE; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVATION; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; LEUKEMIA CELL LINE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN DEGRADATION; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CELL PROTECTION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; ENZYMOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CHROMONES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; HUMANS; INDOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA; MICE; MICE, SCID; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84857408991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0229164     Document Type: Erratum

References (48)

1. Seymour JD, Calle EE, Flagg EW, Coates RJ, Ford ES, et al. (2003) Diet quality index as a predictor of short-term mortality in the American Cancer Society Cancer Prevention Study II Nutrition Cohort. Am J Epidemiol 157: 980-988.
2. Steinmetz KA, Potter JD, (1991) Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2: 325-357.
3. McDanel R, McLean AE, Hanley AB, Heaney RK, Fenwick GR, (1988) Chemical and biological properties of indole glucosinolates (glucobrassicin): A review. Food Chem Toxicol 26: 59-70.
4. Grose KR, Bjeldanes LF, (1992) Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5: 188-193.
5. De Kruif CA, Marsman JW, Venekamp JC, Falke HE, Noordhoek J, et al. (1991) Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact 80: 303-315.
6. Stresser DM, Blanchard AP, Turner SD, Erve JC, Dandeneau AA, et al. (2000) Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab Dispos 28: 1440-1448.
7. Jin L, Qi M, Chen DZ, Anderson A, Yang GY, et al. (1999) Indole-3-carbinol prevents cervical cancer in human papilloma virus type 16 (HPV16) transgenic mice. Cancer Res 59: 3991-3997.
8. Wong GY, Bradlow L, Sepkovic D, Mehl S, Mailman J, et al. (1997) Dose-ranging study of indole-3-carbinol for breast cancer prevention. J Cell Biochem 28-29 (suppl.): 111-116.
9. Hong C, Kim HA, Firestone GL, Bjeldanes LF, (2002) 3,3-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression. Carcinogenesis 23: 1297-1305.
10. Howells LM, Gallacher-Horley B, Houghton CE, Manson MM, Hudson EA, (2002) Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line. Mol Cancer Ther 1: 1161-1172.
11. Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, et al. (2006) Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3, 3′-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15: 2477-2481.
12. Ross JA, Kasum CM, Davies SM, Jacobs DR, Folsom AR, et al. (2002) Diet and risk of leukemia in the Iowa women's health study. Cancer Epidemiology, Biomarkers & Prevention 11: 777-781.
13. Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C, (2003) PI3K/Akt and apoptosis: size matters. Oncogene 22: 8983-8998.
14. Vivanco I, Sawyers CL, (2002) The phosphatidylinositol 3-Kinase-AKT pathway in human cancer. Nat Rev 2: 489-501.
15. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551.
16. Datta SR, Brunet A, Greenberg ME, (1999) Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927.
17. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, et al. (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868.
18. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321.
19. Dhanasekaran DN, Reddy EP, (2008) JNK signaling in apoptosis. Oncogene 27: 6245-6251.
20. Guo YL, Baysal K, Kang B, Yang LJ, Williamson J, (1998) Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 273: 4027-4034.
21. Gong Y, Sohn H, Xue L, Firestone GL, Bjeldanes LF, (2006) 3,3-Diindolylmethane is a novel mitochondrial H+-ATP synthase inhibitor that can induce p21Cip1/Waf1 expression by induction of oxidative stress in human breast cancer cells. Cancer Res 66: 4880-4887.
22. Rahman KM, Sarkar FH, (2005) Inhibition of Nuclear Translocation of Nuclear Factor-κB Contributes to 3,3-Diindolylmethane-Induced Apoptosis in Breast Cancer Cells. Cancer Res 65: 364-371.
23. Chen Y, Xu J, Jhala N, Pawar P, Zhu ZB, et al. (2006) Fas-mediated apoptosis in cholangiocarcinoma cells is enhanced by 3,3′-Diindolylmethane through inhibition of AKT signaling and FLICE-like inhibitory protein. Am J Pathol 169: 1833-1842.
24. Bhuiyan MMR, Li Y, Banerjee S, Ahmed F, Wang Z, et al. (2006) Down-regulation of androgen receptor by 3,3-Diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res 66: 10064-10072.
25. Nachshon-Kedmi1 M, Yannai1 S, Fares FA, (2004) Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway. Brit J Cancer 91: 1358-1363.
26. Kim AH, Khursigara G, Sun X, Franke TF, Chao MV, (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21: 893-901.
27. Burgering BM, Medema RH, (2003) Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 73: 689-701.
28. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, et al. (1999) NF-κB activation by tumor necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85.
29. Cantley LC, Neel BG, (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96: 4240-4245.
30. Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, et al. (2004) Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev 18: 1800-1805.
31. Kandel ES, Skeen J, Majewski N, Di Cristofano A, Pandolfi PP, et al. (2002) Activation of Akt/protein kinase B overcomes a G(2)/M cell cycle checkpoint induced by DNA damage. Mol Cell Biol 22: 7831-7841.
32. Persad S, Attwell S, Gray V, Delcommenne M, Troussard A, et al. (2000) Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA 97: 3207-3212.
33. Liu TC, Lin PM, Chang JG, Lee JP, Chen TP, et al. (2000) Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia. Am J Hematol 63: 170-175.
34. Liu W, Akhand AA, Takeda K, Kawamoto Y, Itoigawa M, et al. (2003) Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ 10: 772-781.
35. Gao N, Rahmani M, Dent P, Grant S, (2005) 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene 24: 3797-3809.
36. Bae J, Donigian JR, Hsueh AJ, (2003) Tankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosis. J Biol Chem 278: 5195-5204.
37. Opferman JT, Iwasaki H, Ong CC, Suh H, Mizuno S-I, et al. (2005) Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 307: 1101-1104.
38. Kuo ML, Chuang SE, Lin MT, Yang SY, (2001) The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 20: 677-685.
39. Araki T, Hayashi M, Watanabe N, Kanuka H, Yoshino J, et al. (2002) Down regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death. Biochem Biophy Res Commun 290: 1275-1281.
40. Kyriakis JM, Avruch J, (2001) Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807-869.
41. Johnson GL, Lapadat R, (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912.
42. Kim YS, Jhon DY, Lee KY, (2004) Involvement of ROS and JNK1 in selenite-induced apoptosis in Chang liver cells. Exp Mol Med 36: 157-164.
43. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, et al. (2004) Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ Res 94: 1483-1491.
44. Song JJ, Lee YJ, (2005) Dissociation of Akt1 from its negative regulator JIP1 is mediated through the ASK1-MEK-JNK signal transduction pathway during metabolic oxidative stress: a negative feedback loop. J Cell Biol 170: 61-72.
45. Tournier C, Hess P, Yang DD, Xu J, Turner TK, et al. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870-874.
46. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ, (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin dependent kinase. Cell 75: 805-816.
47. EL-Deiry WS, (1998) p21/p53, cellular growth control and genomic integrity. Curr Top Microbiol Immunol 227: 121-137.
48. Gartel AL, Tyner AL, (2002) The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 1: 639-649.